1
|
Ma X, Li Y, Chengyan C, Shen Y, Wang H, Li T. Spatial expression of the nonsense-mediated mRNA decay factors UPF3A and UPF3B among mouse tissues. J Zhejiang Univ Sci B 2023; 24:1062-1068. [PMID: 37961809 PMCID: PMC10646394 DOI: 10.1631/jzus.b2300126] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/23/2023] [Accepted: 06/15/2023] [Indexed: 11/15/2023]
Abstract
无义介导的信使RNA(mRNA)降解途径(nonsense-mediated mRNA decay,简称为NMD)是真核生物细胞内一种重要的基因转录后表达调控机制,它积极参与一系列细胞生理和生化过程,控制细胞命运和生命体的组织稳态。NMD的缺陷会导致人类疾病,如神经发育障碍、肿瘤发生和自身免疫疾病等。UPF3 (Up-frameshift protein 3)是一个核心的NMD因子,它最早在酵母中被发现。UPF3A和UPF3B是UPF3在生物进化到脊椎动物阶段出现的两个旁系同源物,在NMD中具有激活或抑制的作用。以往研究发现,UPF3B蛋白几乎在所有哺乳动物器官中均有表达,而UPF3A蛋白在除睾丸外的大多数哺乳动物组织中难以被检测到。解释这一现象的假说为:在NMD途径中,UPF3B具有比UPF3A更高的竞争性结合UPF2的能力,UPF3B和UPF2的结合促使UPF3A成为游离状态,而游离的UPF3A蛋白不稳定且易被降解。此假说提示UPF3A和UPF3B在NMD中存在拮抗作用。在本研究中,我们重新定量评估了UPF3A和UPF3B在野生型成年雄性和雌性小鼠的9个主要组织和生殖器官中的mRNA和蛋白表达,结果证实UPF3A在雄性生殖细胞中表达量最高。令人惊讶的是,我们发现在包括大脑和胸腺在内的大多数组织中,UPF3A与UPF3B的蛋白水平相当,而在小鼠脾、肺组织中,UPF3A表达高于UPF3B。公共基因表达数据进一步支持了上述发现。因此,我们的研究表明了UPF3A是小鼠组织中普遍表达的NMD因子。同时,该研究结果推测:在生理条件下,UPF3A和UPF3B蛋白之间不存在竞争抑制,且UPF3A在多种哺乳动物组织的稳态中发挥重要作用。
Collapse
Affiliation(s)
- Xin Ma
- State Key Laboratory of Microbial Technology, Shandong University, Qingdao 266237, China
| | - Yan Li
- State Key Laboratory of Microbial Technology, Shandong University, Qingdao 266237, China
| | - Chen Chengyan
- State Key Laboratory of Microbial Technology, Shandong University, Qingdao 266237, China
| | - Yanmin Shen
- State Key Laboratory of Microbial Technology, Shandong University, Qingdao 266237, China
| | - Hua Wang
- Key Laboratory of Aging and Cancer Biology of Zhejiang Province, Department of Pathology and Pathophysiology, School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou 311121, China
| | - Tangliang Li
- State Key Laboratory of Microbial Technology, Shandong University, Qingdao 266237, China.
- Key Laboratory of Aging and Cancer Biology of Zhejiang Province, Department of Pathology and Pathophysiology, School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou 311121, China.
| |
Collapse
|
2
|
Nguyen LS, Jolly L, Shoubridge C, Chan WK, Huang L, Laumonnier F, Raynaud M, Hackett A, Field M, Rodriguez J, Srivastava AK, Lee Y, Long R, Addington AM, Rapoport JL, Suren S, Hahn CN, Gamble J, Wilkinson MF, Corbett MA, Gecz J. Transcriptome profiling of UPF3B/NMD-deficient lymphoblastoid cells from patients with various forms of intellectual disability. Mol Psychiatry 2012; 17:1103-15. [PMID: 22182939 PMCID: PMC4281019 DOI: 10.1038/mp.2011.163] [Citation(s) in RCA: 77] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/01/2011] [Revised: 09/27/2011] [Accepted: 10/24/2011] [Indexed: 11/09/2022]
Abstract
The nonsense-mediated mRNA decay (NMD) pathway was originally discovered by virtue of its ability to rapidly degrade aberrant mRNAs with premature termination codons. More recently, it was shown that NMD also directly regulates subsets of normal transcripts, suggesting that NMD has roles in normal biological processes. Indeed, several NMD factors have been shown to regulate neurological events (for example, neurogenesis and synaptic plasticity) in numerous vertebrate species. In man, mutations in the NMD factor gene UPF3B, which disrupts a branch of the NMD pathway, cause various forms of intellectual disability (ID). Using Epstein Barr virus-immortalized B cells, also known as lymphoblastoid cell lines (LCLs), from ID patients that have loss-of-function mutations in UPF3B, we investigated the genome-wide consequences of compromised NMD and the role of NMD in neuronal development and function. We found that ~5% of the human transcriptome is impacted in UPF3B patients. The UPF3B paralog, UPF3A, is stabilized in all UPF3B patients, and partially compensates for the loss of UPF3B function. Interestingly, UPF3A protein, but not mRNA, was stabilised in a quantitative manner that inversely correlated with the severity of patients' phenotype. This suggested that the ability to stabilize the UPF3A protein is a crucial modifier of the neurological symptoms due to loss of UPF3B. We also identified ARHGAP24, which encodes a GTPase-activating protein, as a canonical target of NMD, and we provide evidence that deregulation of this gene inhibits axon and dendrite outgrowth and branching. Our results demonstrate that the UPF3B-dependent NMD pathway is a major regulator of the transcriptome and that its targets have important roles in neuronal cells.
Collapse
Affiliation(s)
- LS Nguyen
- Department of Paediatrics, University of Adelaide, Adelaide, SA, Australia
- Department of Genetic Medicine, SA Pathology, Adelaide, SA, Australia
| | - L Jolly
- Department of Genetic Medicine, SA Pathology, Adelaide, SA, Australia
| | - C Shoubridge
- Department of Paediatrics, University of Adelaide, Adelaide, SA, Australia
- Department of Genetic Medicine, SA Pathology, Adelaide, SA, Australia
| | - WK Chan
- Department of Bioinformatics and Computational Biology, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
| | - L Huang
- Department of Reproductive Medicine, University of California, San Diego, CA, USA
| | - F Laumonnier
- INSERM, U930, Tours, France
- CNRS, ERL3106, Tours, France
- University Francois-Rabelais, UMR ‘Imaging and Brain’, Tours, France
| | - M Raynaud
- INSERM, U930, Tours, France
- University Francois-Rabelais, UMR ‘Imaging and Brain’, Tours, France
- CHRU de Tours, Service de Genetique, Tours, France
| | - A Hackett
- GOLD Service, Hunter Genetics, Newcastle, Australia
| | - M Field
- GOLD Service, Hunter Genetics, Newcastle, Australia
| | - J Rodriguez
- J.C. Self Research Institute, Greenwood Genetic Centre, Greenwood, SC, USA
| | - AK Srivastava
- J.C. Self Research Institute, Greenwood Genetic Centre, Greenwood, SC, USA
| | - Y Lee
- Child Psychiatry Branch, National Institute of Mental Health, Bethesda, MD, USA
| | - R Long
- Child Psychiatry Branch, National Institute of Mental Health, Bethesda, MD, USA
| | - AM Addington
- Child Psychiatry Branch, National Institute of Mental Health, Bethesda, MD, USA
| | - JL Rapoport
- Child Psychiatry Branch, National Institute of Mental Health, Bethesda, MD, USA
| | - S Suren
- Human Developmental Biology Resource, Neural Development Unit, UCL Institute of Child Health, London, UK
| | - CN Hahn
- Department of Molecular Pathology, Centre for Cancer Biology, SA Pathology, Adelaide, SA, Australia
| | - J Gamble
- Centenary Institute of Cancer Medicine & Cell Biology, University of Sydney, NSW, Australia
| | - MF Wilkinson
- Department of Reproductive Medicine, University of California, San Diego, CA, USA
| | - MA Corbett
- Department of Genetic Medicine, SA Pathology, Adelaide, SA, Australia
| | - J Gecz
- Department of Paediatrics, University of Adelaide, Adelaide, SA, Australia
- Department of Genetic Medicine, SA Pathology, Adelaide, SA, Australia
| |
Collapse
|